Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02523235 · ClinicalTrials.gov registry record · Phase 4
Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks
A Phase 4 study of Total Knee Arthroplasty and Post-surgical Pain, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 117
- Enrollment target
- 1
- Study location
NCT02523235: Completed Phase 4 study of Total Knee Arthroplasty and Post-surgical Pain, sponsored by University of California, San Diego.
NCT02523235 is a Phase 4 study of Total Knee Arthroplasty and Post-surgical Pain that has completed, run by University of California, San Diego. The registered enrollment target is 117 participants, below the 291-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02523235, a Phase 4 study of Total Knee Arthroplasty and Post-surgical Pain, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 117 participants
- Enrollment target
- 1
- Study location
Study Summary
Currently, continuous adductor canal and popliteal-sciatic nerve blocks are used commonly for lower extremity post-operative pain control, specifically for total knee arthroplasty and foot/ankle surgery, respectively. A perineural catheter used to infuse local anesthetic for postoperative analgesia may be placed at various locations along the target nerves. Investigations of single-injection peripheral nerve blocks suggest that the onset of the block might be faster with one location over the other; but, the success rates are equivalent. However, remaining unknown is whether there is an optimal location to place a perineural catheter as part of a continuous peripheral nerve block.
Primary Outcome
Numeric Rating Scale for Pain (0-10; 0=no pain and 10=worst imaginable pain)
Conditions Studied
Interventions
- DRUG ropivacaine 0.2%
Study Locations (1)
California
- University California San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2015-08 |
| Est. Completion | 2018-03 |
| Phase | Phase 4 |
What the finished NCT02523235 record still lists
NCT02523235 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 291-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (60% lower).
The record links to 4 conditions, with Total Knee Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which ropivacaine 0.2% is the first listed.
NCT02523235 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02523235 about?
NCT02523235 is a clinical study titled "Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks". Currently, continuous adductor canal and popliteal-sciatic nerve blocks are used commonly for lower extremity post-operative pain control, specifically for total knee arthroplasty and foot/ankle surgery, respectively. A perineural catheter used to infuse local anesthetic for postoperative analgesia ...
What is the current status of trial NCT02523235?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 117 participants. The study started on 2015-08. Estimated completion is 2018-03.
What conditions does trial NCT02523235 study?
This clinical trial studies the following conditions: Total Knee Arthroplasty, Post-surgical Pain, Foot/Ankle Surgery, Catheterization for Postop Analgesia.
What interventions are being tested in trial NCT02523235?
The interventions under investigation include: ropivacaine 0.2% (DRUG).
Who is sponsoring clinical trial NCT02523235?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02523235 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Total Knee Arthroplasty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02523235's enrollment target sits among peer trials
117 16th of 29 higher than 14 of 29 other Total Knee Arthroplasty trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Total Knee Arthroplasty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Prospective, Randomized Parallel Group Study of the Efficacy of Vancomycin Administered Through Intraarticular Injection Versus Intraosseous Injection Versus Intravenous Infusion in Patients Undergoing Total Knee Arthroplasty
RECRUITING · Phase 4
-
Medrol Dosepak for Outpatient Total Knee Arthroplasty
RECRUITING · Phase 4
-
Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty
RECRUITING · Phase 4
-
A Comparison of Subvastus and Midvastus Approaches in Minimally-Invasive Total Knee Arthroplasty
COMPLETED · Phase 4
-
Does Duloxetine Reduce Sub-Acute Pain After Knee Arthroplasty?
COMPLETED · Phase 4
-
Intraoperative VR for Older Patients Undergoing TKA
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia